Economy
Why this Australian investor likes NZ-listed companies
Fund manager believes in NZ's economic recovery, and is putting money behind it.
Retail
The Small Cap Wrap
Why this firm wants to be the waste king of the north
Plus, New Talisman's success spurns auditor, Esquires to India, and more.
Markets
Neuren's 'embarrassment of opportunities'
The pharmaceutical firm is pushing for approval of multiple phase-three trials in 2026.
Prev
